Chiba, Japan

Yoshihiro Oya

This inventor holds 1 USPTO granted patent. Top assignee: Chiba University. Active years: 2013.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yoshihiro Oya in Autoimmune Disease Treatment

Introduction

Yoshihiro Oya is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medical research, particularly in the area of autoimmune diseases. His innovative methods aim to identify compounds that can prevent or treat these complex conditions.

Latest Patents

Yoshihiro Oya holds a patent for a method of identifying a compound for preventing and/or treating an autoimmune disease. This method involves obtaining a BTLA NKT cell from a non-human animal and contacting it ex vivo with a test compound in the presence of an antigen. The response of the BTLA NKT cell to the antigen is measured and compared to a control assay. The compound that reduces the response of the BTLA NKT cell in the presence of the antigen is selected as a potential treatment. This patent highlights his innovative approach to tackling autoimmune diseases.

Career Highlights

Oya is affiliated with Chiba University, where he conducts his research and development. His work has garnered attention for its potential impact on the treatment of autoimmune diseases. With a focus on scientific rigor and practical applications, he continues to advance the field.

Collaborations

Yoshihiro Oya collaborates with Norihiko Watanabe, contributing to the research and development of new therapeutic methods. Their partnership enhances the scope and depth of their investigations into autoimmune diseases.

Conclusion

Yoshihiro Oya's innovative methods and dedication to research represent a significant advancement in the treatment of autoimmune diseases. His contributions are paving the way for new therapeutic options that could benefit many patients in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…